We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Carecapital | LSE:CARE | London | Ordinary Share | GB00B16JQ761 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.815 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
03/2/2012 12:49 | Doubt that barnetpeter, you can sell loads at the mid price (2.15p) but cannot even get a quote to buy 25k online. Strange how when you were in these it was 10p talk now it's 1.75p :-)) | 27howard | |
03/2/2012 11:39 | Patience - you should get these at 1.75 approx next week as the early punters get their cash and move on. There wil be another rally soon enough. | barnetpeter | |
02/2/2012 14:13 | And it has, 75k max offer, even 25k is full 2.7p to buy bounce time coming. | 27howard | |
02/2/2012 10:58 | 789k sale at 2.25p, that's why the cheap stock, most has found a new home now. | 27howard | |
02/2/2012 10:13 | Last 4 trades are buys, no selling for ages but they have slashed the price repeatedly, looks good value now. | 27howard | |
02/2/2012 10:10 | 2.44p to buy, some 2p cheaper than highest price paid on the spike. I did some checking, might be wrong but 23 mil for German Sale and then 15 mil of sales next two years of UK sites, thats 38 million, leaving a UK business worth 7 million and a 30% stake in a possible cancer blockbuster. All that for 2 million, almost too good to be true, take out the 30 mil of borrowings etc, it my maths are not wrong it could mean them sitting on 5-8 mil of cash and the business and cancer stake for 2 mil ? I must be wrong ? | 27howard | |
02/2/2012 09:23 | No ...hot money moving out. I expect care to fall back to around 2p now. Added myself too high. Will be buying more lower down though ...think this has a lot of potential but folk just happy to grab a few pounds in these tough small cap mkts and i dont blame them at all. | barnetpeter | |
02/2/2012 09:21 | oh ffs :0 ( | jenny tulwought | |
01/2/2012 13:31 | crosswire - 31 Jan'12 - 15:51 - 425 of 444 Wonder if share price will rise like ATG did!! ==================== Nope is the answer | ihavenoclue | |
01/2/2012 10:55 | Glad my broker was off the boil, my shares still in account. | 27howard | |
01/2/2012 10:54 | That was a nice little shake :) | ihavenoclue | |
01/2/2012 10:20 | Mm's are playing games . Wanted to 50k shares and been quoted 3.25p offer was 2.9. | borsya | |
01/2/2012 09:55 | 27howard yes there are lot of sellers today but it may change | khalid | |
01/2/2012 09:50 | Quite a bit of profit taking, put a stop on mine at 3p hoping that level will hold. | 27howard | |
01/2/2012 08:44 | Well that's how they make their living khalid :-)) | 27howard | |
01/2/2012 08:41 | khalid are you a novice? do u understand how the mms operate | 48max | |
01/2/2012 08:40 | 27howard you are right the mm will bring out weak sellers and shift stock on at higher price thanks for that good luck | khalid | |
01/2/2012 08:36 | kahlid At the open you could not buy but as the price moves up the mm will offer stock and play their games. | 27howard | |
01/2/2012 08:31 | 27howard cant understand if your saying there is no stock then where are the sellers coming from? | khalid | |
01/2/2012 08:02 | Cant even buy 10k at open hence no trades. | 27howard | |
01/2/2012 06:18 | Shares in CareCapital* (CARE) rocketed 1.75p, or 117% to 3.25p, as the board confirmed the sale of its entire German portfolio for 27.35 million euros would allow it to realise the value of its UK healthcare development pipeline. The firm has a number of projects in progress in the UK which includes the construction of medical centres in Coventry, West Wirral Bishops Stortford and a further four in Wales - boasting a capital value upon completion of 21.8 million pounds to the group. The board added it believes CareCapital's 28.75% shareholding in Advanced Proton Solutions has the potential to be of significant value. The cancer treatment technology group's proton beam therapy is reportedly widely recognised as the most effective treatment for a variety of cancer conditions. | crosswire | |
31/1/2012 16:44 | Overseas Centres treating UK patients Service Locations: Paul Scherrer Institut, Villigen, Switzerland University of Florida Proton Therapy Insitute (UFPTI), Florida, USA ProCure Proton Therapy Centre, Oklahoma, USA ++++++++++++++++++++ No Proton Beam Therapy Centre as yet in the UK!!!! CARE has : Planning secured for first Proton Beam Therapy Centre in the City of London for 28.75% owned Advanced Proton Solutions, four more centres in the pipeline in the USA | crosswire | |
31/1/2012 16:40 | Highlights · Deleveraging strategy continued - sale of German portfolio post period end eliminates Euro debt and provides working capital · Significantly reduced loss for the first half of 2011 · Remaining pipeline of UK healthcare developments now largely pre-sold to reduce financial risk and secure development profits · Planning secured for first Proton Beam Therapy Centre in the City of London for 28.75% owned Advanced Proton Solutions, four more centres in the pipeline in the USA Dr. Michael Sinclair, Chairman, commented, "We are, thankfully, now in a position to start to rebuild value for shareholders - now that CareCapital has substantially deleveraged - through our interests in the remaining UK healthcare development pipeline and in perhaps the world's fastest growing cancer treatment sector." | crosswire | |
31/1/2012 16:37 | Proton beam therapy is the next generation in radiation therapy treating solid tumors. Unlike conventional radiation, proton beam therapy can deliver a highly precise and direct dose of radiation to the tumor, minimizing damage to surrounding healthy tissue and reducing side effects. | crosswire |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions